Found: 61
Select item for more details and to access through your institution.
Abatacept used in combination with nonmethotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. 1, doi. 10.1186/s13075-017-1488-5
- By:
- Publication type:
- Article
Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1548, doi. 10.3390/jcm8101548
- By:
- Publication type:
- Article
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1016927
- By:
- Publication type:
- Article
ORAL SURVEILLANCE: Was hat sich an der Risikobeurteilung von JAK-Inhibitoren geändert?
- Published in:
- Zeitschrift für Rheumatologie, 2022, v. 81, n. 9, p. 780, doi. 10.1007/s00393-022-01252-y
- By:
- Publication type:
- Article
Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0014328
- By:
- Publication type:
- Article
Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure.
- Published in:
- European Journal of Health Economics, 2010, v. 11, n. 1, p. 95, doi. 10.1007/s10198-009-0205-y
- By:
- Publication type:
- Article
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7316, doi. 10.3390/jcm11247316
- By:
- Publication type:
- Article
Lungenbeteiligung bei rheumatoider Arthritis.
- Published in:
- Zeitschrift für Rheumatologie, 2019, v. 78, n. 3, p. 228, doi. 10.1007/s00393-019-0611-1
- By:
- Publication type:
- Article
Lymphome bei rheumatischen Erkrankungen.
- Published in:
- Zeitschrift für Rheumatologie, 2017, v. 76, p. 46, doi. 10.1007/s00393-017-0383-4
- By:
- Publication type:
- Article
Lungenkarzinom und rheumatoide Arthritis.
- Published in:
- Zeitschrift für Rheumatologie, 2016, v. 75, n. 1, p. 47, doi. 10.1007/s00393-016-0043-0
- By:
- Publication type:
- Article
Brauchen wir noch klinische Studien in der Rheumatologie?
- Published in:
- Zeitschrift für Rheumatologie, 2016, v. 75, n. 1, p. 4, doi. 10.1007/s00393-015-1687-x
- By:
- Publication type:
- Article
Wechsel innerhalb der Wirkstoffgruppe oder Wechsel des Wirkprinzips.
- Published in:
- Zeitschrift für Rheumatologie, 2015, v. 74, n. 5, p. 406, doi. 10.1007/s00393-014-1533-6
- By:
- Publication type:
- Article
Evidenzbasierte Empfehlungen zum Management einer undifferenzierten peripheren entzündlichen Arthritis (UPIA).
- Published in:
- Zeitschrift für Rheumatologie, 2014, v. 73, n. 4, p. 363, doi. 10.1007/s00393-013-1249-z
- By:
- Publication type:
- Article
Empfehlungen zum Einsatz von Rituximab bei ANCA-assoziierten Vaskulitiden.
- Published in:
- Zeitschrift für Rheumatologie, 2014, v. 73, n. 3, p. 287, doi. 10.1007/s00393-013-1318-3
- By:
- Publication type:
- Article
Empfehlungen zum Einsatz von Rituximab bei Patienten mit rheumatoider Arthritis.
- Published in:
- Zeitschrift für Rheumatologie, 2014, v. 73, n. 2, p. 165, doi. 10.1007/s00393-013-1238-2
- By:
- Publication type:
- Article
Nebenwirkungen der medikamentösen Therapie rheumatischer Erkrankungen am Nervensystem.
- Published in:
- Zeitschrift für Rheumatologie, 2012, v. 71, n. 7, p. 572, doi. 10.1007/s00393-012-0959-y
- By:
- Publication type:
- Article
Neue Kinasehemmer.
- Published in:
- Zeitschrift für Rheumatologie, 2012, v. 71, n. 6, p. 479, doi. 10.1007/s00393-011-0880-9
- By:
- Publication type:
- Article
'Orphan diseases' in der Rheumatologie.
- Published in:
- Zeitschrift für Rheumatologie, 2012, v. 71, n. 2, p. 119, doi. 10.1007/s00393-011-0902-7
- By:
- Publication type:
- Article
Strategien zur verbesserten Versorgung von Menschen mit der Volkskrankheit 'Rheuma' am Beispiel der rheumatoiden Arthritis.
- Published in:
- Zeitschrift für Rheumatologie, 2011, v. 70, n. 8, p. 641, doi. 10.1007/s00393-011-0763-0
- By:
- Publication type:
- Article
Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich?
- Published in:
- Zeitschrift für Rheumatologie, 2011, v. 70, n. 6, p. 517, doi. 10.1007/s00393-011-0827-1
- By:
- Publication type:
- Article
§ 116b SGB V in der rheumatologischen Versorgung.
- Published in:
- Zeitschrift für Rheumatologie, 2011, v. 70, n. 1, p. 56, doi. 10.1007/s00393-010-0703-4
- By:
- Publication type:
- Article
Tocilizumab.
- Published in:
- Zeitschrift für Rheumatologie, 2010, v. 69, n. 7, p. 608, doi. 10.1007/s00393-009-0529-0
- By:
- Publication type:
- Article
Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Einsatz von Tocilizumab bei der rheumatoiden Arthritis (Februar 2010).
- Published in:
- Zeitschrift für Rheumatologie, 2010, v. 69, n. 4, p. 365, doi. 10.1007/s00393-010-0612-6
- By:
- Publication type:
- Article
Grußwort.
- Published in:
- Zeitschrift für Rheumatologie, 2009, v. 68, n. 0, p. 1, doi. 10.1007/s00393-009-0544-1
- By:
- Publication type:
- Article
Anti-B-Zell-Strategien bei Vaskulitiden und Kollagenosen.
- Published in:
- Zeitschrift für Rheumatologie, 2009, v. 68, n. 5, p. 390, doi. 10.1007/s00393-009-0439-1
- By:
- Publication type:
- Article
Empfehlungen zum Einsatz von Rituximab bei Patienten mit rheumatoider Arthritis.
- Published in:
- Zeitschrift für Rheumatologie, 2008, v. 67, n. 7, p. 609
- By:
- Publication type:
- Article
Impfungen in der Erwachsenenrheumatologie.
- Published in:
- Zeitschrift für Rheumatologie, 2007, v. 66, n. 2, p. 102, doi. 10.1007/s00393-007-0144-x
- By:
- Publication type:
- Article
Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?
- Published in:
- European Journal of Clinical Investigation, 2022, v. 52, n. 2, p. 1, doi. 10.1111/eci.13713
- By:
- Publication type:
- Article
Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients.
- Published in:
- Arthritis Research & Therapy, 2014, v. 16, n. 1, p. R80, doi. 10.1186/ar4521
- By:
- Publication type:
- Article
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy.
- Published in:
- Rheumatology, 2023, v. 62, n. 1, p. 89, doi. 10.1093/rheumatology/keac285
- By:
- Publication type:
- Article
Anti-interleukin-23-directed therapy and the recurrence of severe allergic asthma.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study).
- Published in:
- Rheumatology, 2021, v. 60, n. 11, p. 5318, doi. 10.1093/rheumatology/keab153
- By:
- Publication type:
- Article
Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4755, doi. 10.1093/rheumatology/keab097
- By:
- Publication type:
- Article
Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 682, doi. 10.1093/rheumatology/keaa259
- By:
- Publication type:
- Article
061 Rapid response with upadacitinib treatment in patients with rheumatoid arthritis and an inadequate response to csDMARDS or bDMARDS.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
- Published in:
- Rheumatology, 2017, v. 56, n. 5, p. 689, doi. 10.1093/rheumatology/kew271
- By:
- Publication type:
- Article
Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.
- Published in:
- Rheumatology, 2017, v. 56, n. 4, p. 541, doi. 10.1093/rheumatology/kew370
- By:
- Publication type:
- Article
Assessing the safety of biologic agents in patients with rheumatoid arthritis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs.
- Published in:
- Rheumatology, 2012, v. 51, n. suppl_5, p. v12, doi. 10.1093/rheumatology/kes111
- By:
- Publication type:
- Article
Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Assessing the safety of biologic agents in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2012, v. 51, n. suppl_5, p. v38, doi. 10.1093/rheumatology/kes114
- By:
- Publication type:
- Article
Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis.
- Published in:
- Rheumatology, 2011, v. 50, n. 12, p. 2223, doi. 10.1093/rheumatology/ker253
- By:
- Publication type:
- Article
Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply.
- Published in:
- Rheumatology, 2011, v. 50, n. 3, p. 632, doi. 10.1093/rheumatology/keq401
- By:
- Publication type:
- Article
Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR).
- Published in:
- Rheumatology, 2010, v. 49, n. 9, p. 1683, doi. 10.1093/rheumatology/keq116
- By:
- Publication type:
- Article
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 9, p. 2377, doi. 10.1007/s10067-023-06662-0
- By:
- Publication type:
- Article
Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.
- Published in:
- Medical Microbiology & Immunology, 2015, v. 204, n. 5, p. 613, doi. 10.1007/s00430-015-0390-5
- By:
- Publication type:
- Article
Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.
- Published in:
- Multiple Sclerosis (13524585), 2009, v. 15, n. 2, p. 189, doi. 10.1177/1352458508098268
- By:
- Publication type:
- Article
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 5, p. 1197, doi. 10.1007/s40744-024-00694-x
- By:
- Publication type:
- Article
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 737, doi. 10.1007/s40744-024-00671-4
- By:
- Publication type:
- Article